Elevance Health to Acquire BioPlus Specialty Pharmacy
November 9, 2022
Elevance Health announced it entered into an agreement to acquire BioPlus, a comprehensive specialty pharmacy that provides services for complex and chronic conditions such as cancer and autoimmune diseases. The deal is expected to close in the first half of 2023 and will integrate BioPlus into Elevance Health’s pharmacy benefit manager, IngenioRx, within its Carelon healthcare services brand.
- Buyers
- Elevance Health
- Targets
- BioPlus
- Sellers
- CarepathRx (portfolio company of Nautic Partners)
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Elevance Health Acquires Paragon Healthcare
March 11, 2024
Healthcare Services
Elevance Health closed its acquisition of Paragon Healthcare, an infusion services and injectable therapy provider. Following the deal, Paragon Healthcare will operate as part of CarelonRx, Elevance’s pharmacy services segment, with plans to expand geographically and scale multi-site infusion services and specialty pharmacy capabilities.
-
Elevance Health Acquires Blue Cross and Blue Shield of Louisiana
January 23, 2023
Insurance
Elevance Health has entered into a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). The transaction will integrate BCBSLA into Elevance's Anthem Blue Cross Blue Shield family, keep the Louisiana headquarters and workforce local, and expand Elevance's capabilities and footprint in Louisiana.
-
Revelation Pharma Acquires Cascade Specialty Pharmacy
January 22, 2025
Healthcare Services
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Cascade Specialty Pharmacy of Poulsbo, Washington. The acquisition expands Revelation Pharma's ENT and animal-health compounding capabilities and brings Cascade's existing customers and product lines into Revelation's national fulfillment network; Cascade's former owner Brandon Knott will remain involved as an ENT Allergy Product Specialist.
-
AmerisourceBergen Acquires PharmaLex for €1.28 Billion
December 31, 2022
Healthcare Services
AmerisourceBergen Corporation signed a definitive agreement to acquire PharmaLex Holding GmbH for €1.28 billion in cash. The deal is intended to expand AmerisourceBergen’s global biopharma services platform by adding PharmaLex’s tech-enabled, regulatory-focused life sciences expertise.
-
Navitus Health Solutions Acquires EpiphanyRx; Lumicera Purchases Quality Drug Clinical Care
July 19, 2021
Healthcare Services
Navitus Health Solutions has acquired EpiphanyRx to broaden its PBM capabilities and mid-market employer reach. Its specialty pharmacy arm, Lumicera Health Services, also acquired Quality Drug Clinical Care in Irvine, California to expand Lumicera's specialty pharmacy footprint and HIV clinical services in the western United States.
-
Harmony Biosciences Acquires Epygenix Therapeutics
April 30, 2024
Biotechnology
Harmony Biosciences has acquired Epygenix Therapeutics, adding a late-stage rare epilepsy franchise (including EPX-100 and EPX-200) to its CNS pipeline. Harmony paid $35 million in cash with up to $130 million in development/regulatory milestones and up to $515 million in potential sales milestones to complete the transaction.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.